• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

A single dose of psilocybin eased depression symptoms for months, our study found

The Conversation | Cannabis Pic/Shutterstock
The Conversation | Cannabis Pic/Shutterstock

Although several studies have explored psilocybin for depression, many have focused on people whose symptoms had not responded to other treatments (so-called “treatment-resistant depression”). We wanted to test whether the drug could also help people with more common forms of depression. At just eight days, those who received psilocybin showed noticeable improvements in mood. And by the end of the six-week follow-up period, more than half of participants in the psilocybin group no longer met the criteria for depression. In the placebo group, only one person showed the same level of improvement.

Posted in: News on 05/28/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice